IPV: Clinical Trials

6 completed. 6 Phase 3.

By phase and status

Phase	Trials	Status
Phase 3	6	Completed 6

Follow IPV: new trials by email Literature Review of IPV trials Research Report on IPV

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study on the Immune Response and Safety of Inactivated Poliovirus Vaccine (IPV) When Co-administered With Human Rotavirus (HRV) Porcine Circovirus (PCV)-Free Vaccine in Healthy Chinese Infants HRV PCV-free, IPV - Gastroenteritis	Phase 3	Completed	GlaxoSmithKline	400	2024-03-22	2025-10-22
Immunogenicity and Safety of Concomitant and Non-Concomitant Administration of RotaTeq® (V260) and Inactivated Poliomyelitis Vaccine in Healthy Chinese Infants (V260-074) RotaTeq (V260), IPV - Prevention of Rotavirus Gastroenteritis in Infants and Children Caused by Serotypes G1, G2, G3, G4, and G9	Phase 3	Completed	Merck Sharp & Dohme LLC	400	2020-08-25	2024-07-26
A Study to Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPV IPV, f-IPV - Poliomyelitis	Phase 3	Completed	Fidec Corporation	773	2017-10-23	2023-07-21
Immunogenicity and Safety Study of Booster Dose of GSK Biologicals' IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) Vaccine Infanrix+Hib™, Poliorix™ - Acellular Pertussis, Tetanus	Phase 3	Completed	GlaxoSmithKline	831	2011-10-01	2018-06-06
Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines Synflorix, Tritanrix-HepB, Hiberix - Infections, Streptococcal	Phase 3	Completed	GlaxoSmithKline	756	2007-10-22	2019-01-14
Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine Pneumococcal conjugate vaccine GSK1024850A, Prevenar, Tritanrix-HepB - Infections, Streptococcal	Phase 3	Completed	GlaxoSmithKline	806	2006-08-07	2018-12-07

Conditions studied

Pneumococcal Infections (2)  ·  Streptococcal Infections (2)  ·  Diphtheria (1)  ·  Gastroenteritis (1)  ·  Haemophilus Infections (1)  ·  Poliomyelitis (1)  ·  Tetanus (1)

Sponsors

GlaxoSmithKline (4)  ·  Fidec Corporation (1)  ·  Merck Sharp & Dohme LLC (1)

Countries

China (3)  ·  Philippines (2)  ·  Poland (2)  ·  Dominican Republic (1)  ·  Panama (1)

Results publications

PMID 19325447, PMID 19325451, PMID 19325452, PMID 33284114, PMID 38509699